The first Atricure trade was made in Q1 2023. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Atricure anymore.
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left at...
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ETCompany ParticipantsMarissa Bych – Gilmartin Group, Investor…
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q2 2023 Earnings Conference Call July 25, 2023 4:30 PM ETCompany ParticipantsMarissa Bych - Vice President-Gilmartin Grou...
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ETCompany ParticipantsMarissa Bych – Vice President-Gilmartin GroupM...